RE:RE:RE:11.81 - down 30% ytdStyless wrote: A Comp to an investor is another company that would give you similar exposure to the canadian listed healthcare sector.
Look at CRH, CXV, PHM, NHC, GUD, CXR. There are a ton of better companies with better outlooks than CPH. I would argue CPH ranks dead last against these companies. That's a clear fact given the ~90% underperformance.
Are any of those attractively valued? I ran the first three and there are some fast growing companies there, but all absurdly overpriced. Why chase growth at a high price?
It looks to me like Cipher screwed up an important drug. The Ranbaxy tie-up looks like a mess, and effectively there is no effective sales force there. But Cipher does have high return on equity, and once the price comes down a little, it might make an attractively priced investment. I would not touch it here.